The Molecular Medicine Ireland, Chief Executive, will playing a central role in building Ireland’s capacity for patient focused
The mission of Molecular Medicine Ireland is to mobilise the strengths of the five partner institutions NUI Galway, RCSI, TCD, UCC and UCD, their associated hospitals and clinical research facilities, to build a sustainable national system to coordinate, support and promote translational and clinical research so that advances in science can be readily turned into better health outcomes. In this task, MMI works closely with stakeholders in academia, the public and private sectors. For more information on MMI and its mission see www.molecularmedicineireland.ie
MMI wish to recruit a Chief Executive with a proven track record in Clinical Practice and, or Research. The successful candidate will have a strong understanding and experience of the biomedical research landscape at a strategic level in Ireland and internationally. He or she will be a proven leader with, excellent interpersonal, influencing and networking skills and be clinically attuned and familiar with the challenges of translational medicine.
A full detailed job description and person specification are available on request. The attractive remuneration package on offer is commensurate with the seniority of the post. The post is being offered on a five year fixed term basis. Applicants are invited to submit a detailed CV and any other pertinent supporting documentation they feel will support their application to Siobhan Browne by July 15th 2016. The formal selection process will commence in September 2016. For further details, or an informal discussion, contact Siobhan Browne, Siobhan Browne and Associates Limited on 086 8263957, or email email@example.com.
For details of the position see www.molecularmedicineireland.ie